These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 19015468

  • 1. Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer.
    Min BS, Choi YJ, Pyo HR, Kim H, Seong J, Chung HC, Rha SY, Kim NK.
    Arch Surg; 2008 Nov; 143(11):1091-7; discussion 1097. PubMed ID: 19015468
    [Abstract] [Full Text] [Related]

  • 2. COX-2 overexpression in pretreatment biopsies predicts response of rectal cancers to neoadjuvant radiochemotherapy.
    Smith FM, Reynolds JV, Kay EW, Crotty P, Murphy JO, Hollywood D, Gaffney EF, Stephens RB, Kennedy MJ.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):466-72. PubMed ID: 16213106
    [Abstract] [Full Text] [Related]

  • 3. Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer.
    Yeo SG, Kim DY, Kim TH, Jung KH, Hong YS, Chang HJ, Park JW, Lim SB, Choi HS, Jeong SY.
    Int J Radiat Oncol Biol Phys; 2010 Sep 01; 78(1):164-71. PubMed ID: 20004532
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of volumetric analysis, histopathologic downstaging, and tumor regression grade in evaluating tumor response in locally advanced rectal cancer following preoperative chemoradiation.
    Kim NK, Baik SH, Min BS, Pyo HR, Choi YJ, Kim H, Seong J, Keum KC, Rha SY, Chung HC.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):204-10. PubMed ID: 17084555
    [Abstract] [Full Text] [Related]

  • 5. Absence of cyclooxygenase-2 protein expression is a predictor of tumor regression in rectal cancer treated with preoperative short-term chemoradiotherapy.
    Kobayashi H, Hashiguchi Y, Ueno H, Shinto E, Kajiwara Y, Mochizuki H.
    Dis Colon Rectum; 2007 Sep 01; 50(9):1354-62. PubMed ID: 17308999
    [Abstract] [Full Text] [Related]

  • 6. Tumor volume changes assessed by three-dimensional magnetic resonance volumetry in rectal cancer patients after preoperative chemoradiation: the impact of the volume reduction ratio on the prediction of pathologic complete response.
    Kang JH, Kim YC, Kim H, Kim YW, Hur H, Kim JS, Min BS, Kim H, Lim JS, Seong J, Keum KC, Kim NK.
    Int J Radiat Oncol Biol Phys; 2010 Mar 15; 76(4):1018-25. PubMed ID: 19647949
    [Abstract] [Full Text] [Related]

  • 7. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy.
    Bouzourene H, Bosman FT, Seelentag W, Matter M, Coucke P.
    Cancer; 2002 Feb 15; 94(4):1121-30. PubMed ID: 11920483
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy.
    Giralt J, Navalpotro B, Hermosilla E, de Torres I, Espin E, Reyes V, Cerezo L, de las Heras M, Ramon y Cajal S, Armengol M, Benavente S.
    Oncology; 2006 Feb 15; 71(5-6):312-9. PubMed ID: 17687192
    [Abstract] [Full Text] [Related]

  • 9. The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.
    Edden Y, Wexner SD, Berho M.
    Colorectal Dis; 2012 May 15; 14(5):555-61. PubMed ID: 21689364
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
    Kulke MH, Odze RD, Mueller JD, Wang H, Redston M, Bertagnolli MM.
    J Thorac Cardiovasc Surg; 2004 Jun 15; 127(6):1579-86. PubMed ID: 15173710
    [Abstract] [Full Text] [Related]

  • 11. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D, Hyland JM, Winter DC, Lim C, White A, Moriarty M, Armstrong J, Fennelly D, Gibbons D, Sheahan K.
    Ann Surg Oncol; 2008 Dec 15; 15(12):3471-7. PubMed ID: 18846402
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.
    Vecchio FM, Valentini V, Minsky BD, Padula GD, Venkatraman ES, Balducci M, Miccichè F, Ricci R, Morganti AG, Gambacorta MA, Maurizi F, Coco C.
    Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):752-60. PubMed ID: 15936556
    [Abstract] [Full Text] [Related]

  • 16. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Bertolini F, Bengala C, Losi L, Pagano M, Iachetta F, Dealis C, Jovic G, Depenni R, Zironi S, Falchi AM, Luppi G, Conte PF.
    Int J Radiat Oncol Biol Phys; 2007 Aug 01; 68(5):1455-61. PubMed ID: 17445998
    [Abstract] [Full Text] [Related]

  • 17. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.
    Xi H, Baldus SE, Warnecke-Eberz U, Brabender J, Neiss S, Metzger R, Ling FC, Dienes HP, Bollschweiler E, Moenig S, Mueller RP, Hoelscher AH, Schneider PM.
    Clin Cancer Res; 2005 Dec 01; 11(23):8341-7. PubMed ID: 16322294
    [Abstract] [Full Text] [Related]

  • 18. The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer.
    Berho M, Oviedo M, Stone E, Chen C, Nogueras J, Weiss E, Sands D, Wexner S.
    Colorectal Dis; 2009 Mar 01; 11(3):254-8. PubMed ID: 18513188
    [Abstract] [Full Text] [Related]

  • 19. Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy.
    Barbaro B, Vitale R, Valentini V, Illuminati S, Vecchio FM, Rizzo G, Gambacorta MA, Coco C, Crucitti A, Persiani R, Sofo L, Bonomo L.
    Int J Radiat Oncol Biol Phys; 2012 Jun 01; 83(2):594-9. PubMed ID: 22099033
    [Abstract] [Full Text] [Related]

  • 20. Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer.
    Tweedle EM, Khattak I, Ang CW, Nedjadi T, Jenkins R, Park BK, Kalirai H, Dodson A, Azadeh B, Terlizzo M, Grabsch H, Mueller W, Myint S, Clark P, Wong H, Greenhalf W, Neoptolemos JP, Rooney PS, Costello E.
    Gut; 2010 Nov 01; 59(11):1501-10. PubMed ID: 20947885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.